General Cannabis Corp (NASDAQ:CANN) CEO Robert Lawrence Frichtel sold 75,000 shares of the stock in a transaction on Monday, October 17th. The shares were sold at an average price of $3.59, for a total transaction of $269,250.00. Following the completion of the transaction, the chief executive officer now owns 906,000 shares of the company’s stock, valued at approximately $3,252,540. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Robert Lawrence Frichtel also recently made the following trade(s):

  • On Wednesday, October 12th, Robert Lawrence Frichtel sold 25,000 shares of General Cannabis Corp stock. The shares were sold at an average price of $3.71, for a total transaction of $92,750.00.

Shares of General Cannabis Corp (NASDAQ:CANN) traded up 16.83% during trading on Tuesday, hitting $4.86. 2,700,175 shares of the stock were exchanged. General Cannabis Corp has a 1-year low of $0.32 and a 1-year high of $5.19. The company’s market cap is $75.31 million. The firm’s 50-day moving average is $1.71 and its 200 day moving average is $1.15.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

General Cannabis Corp Company Profile

General Cannabis Corporation offers various products and services to companies in the cannabis industry. The Company’s integrated solution ranges from operational and compliance consulting to security and marketing to financing needs. The Company’s segments include Security and Cash Management Services; Marketing and Products; Consulting and Advisory, and Finance and Real Estate.

5 Day Chart for NASDAQ:CANN

Receive News & Ratings for General Cannabis Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for General Cannabis Corp and related companies with's FREE daily email newsletter.